Literature DB >> 15564375

FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.

Xuan Li1, Valerie G Brunton, Helen R Burgar, Lee M Wheldon, John K Heath.   

Abstract

Activation of signalling by fibroblast growth factor receptor leads to phosphorylation of the signalling attenuator human Sprouty 2 (hSpry2) on residue Y55. This event requires the presence of the signalling adaptor fibroblast growth factor receptor substrate 2 (FRS2). The phosphorylation of hSpry2 is therefore mediated by an intermediate kinase. Using a SRC family kinase-specific inhibitor and mutant cells, we show that hSpry2 is a direct substrate for SRC family kinases, including SRC itself. Activation of SRC via fibroblast growth factor signalling is dependent upon FRS2 and fibroblast growth factor receptor kinase activity. SRC forms a complex with hSpry2 and this interaction is enhanced by hSpry2 phosphorylation. Phosphorylation of hSpry2 is required for hSpry2 to inhibit activation of the extracellular signal-regulated kinase pathway. These results show that recruitment of SRC to FRS2 leads to activation of signal attenuation pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564375     DOI: 10.1242/jcs.01519

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  15 in total

Review 1.  An essential role for FGF receptor signaling in lens development.

Authors:  Michael L Robinson
Journal:  Semin Cell Dev Biol       Date:  2006-10-27       Impact factor: 7.727

2.  Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors.

Authors:  Emma Sandilands; Shiva Akbarzadeh; Anna Vecchione; David G McEwan; Margaret C Frame; John K Heath
Journal:  EMBO Rep       Date:  2007-11-02       Impact factor: 8.807

Review 3.  Fibroblast growth factor signaling in the vasculature.

Authors:  Xuehui Yang; Lucy Liaw; Igor Prudovsky; Peter C Brooks; Calvin Vary; Leif Oxburgh; Robert Friesel
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

4.  ZDHHC3 Tyrosine Phosphorylation Regulates Neural Cell Adhesion Molecule Palmitoylation.

Authors:  Patricia Marie-Jeanne Lievens; Tatiana Kuznetsova; Gaga Kochlamazashvili; Fabrizia Cesca; Natalya Gorinski; Dalia Abdel Galil; Volodimir Cherkas; Natalia Ronkina; Juri Lafera; Matthias Gaestel; Evgeni Ponimaskin; Alexander Dityatev
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

5.  Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification.

Authors:  Anna A Dudka; Steve M M Sweet; John K Heath
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

6.  A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.

Authors:  Satoshi Yamaji; Jun Saegusa; Katsuaki Ieguchi; Masaaki Fujita; Seiji Mori; Yoko K Takada; Yoshikazu Takada
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

7.  Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.

Authors:  Debbie L Cunningham; Steve M M Sweet; Helen J Cooper; John K Heath
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

8.  N-methyl-D-aspartate receptors mediate diphosphorylation of extracellular signal-regulated kinases through Src family tyrosine kinases and Ca2+/calmodulin-dependent protein kinase II in rat hippocampus after cerebral ischemia.

Authors:  Hui-Wen Wu; Hong-Fu Li; Jun Guo
Journal:  Neurosci Bull       Date:  2007-03       Impact factor: 5.203

9.  Regulation of sprouty stability by Mnk1-dependent phosphorylation.

Authors:  John DaSilva; Lizhong Xu; Hong Joo Kim; W Todd Miller; Dafna Bar-Sagi
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

10.  SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.

Authors:  A Barbáchano; A Fernández-Barral; F Pereira; M F Segura; P Ordóñez-Morán; E Carrillo-de Santa Pau; J M González-Sancho; D Hanniford; N Martínez; A Costales-Carrera; F X Real; H G Pálmer; J M Rojas; E Hernando; A Muñoz
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.